LLC Feron
ABOUT
LLC Feron was established in 1998. The company produces medicines based on recombinant interferon alpha-2b and conducts research on interferon and immune systems in adults and children with various infectious and inflammatory diseases. Rectal suppositories Viferon® are the key product of LLC Feron. The drug has passed a full cycle of clinical trials with a wide range of diseases in leading clinics in Russia. As a result of a fundamental research conducted in the department of interferons of the Institute of Epidemiology and Microbiology n.a. Gamalei RAMS (Moscow) it became possible to avoid the side effects arising from the parenteral administration of recombinant interferons and to achieve a reduction in interferon dosage and prolongation of its effect after a single administration. Viferon ® combines well with other drugs during complex therapy of different diseases. Viferon does not develop addiction and resistance.
ACTIVITY CLASS (NACE Rev.2)
21.20 Manufacture of pharmaceutical preparations
CURRENT EXPORT MARKETS
Belarus, Moldova, Kazakhstan, Uzbekistan, Georgia, Azerbaijan, Kyrgyzstan, Armenia, Turkmenistan, Tajikistan, Mongolia
CLASS OF GOODS (HS 2017)
300215 Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, put up in measured doses or in forms or packings for retail sale